SOX2 and prostate cancer: In terms of cancer, it was recently demonstrated that prostate cancer stem cells are characterized by high E-cadherin expression, are highly invasive, and exhibit high expression of stem cell markers Oct-3/4 and Sox2 compared to cells with low E-cadherin expression [36,37].